Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/clinchem/hvab217 http://scihub22266oqcxt.onion/10.1093/clinchem/hvab217 34969112!9383166!34969112     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Chem 2021 ; 68 (1): 83-90 Nephropedia Template TP {{tp|p=34969112|t=2021. Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance |pdf=|usr=}}{{34969112}} gab.com Text Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance JO: Clin Chem http://www.kidney.de/pget.php?&tw=1&pmid=34969112 #FOAvip BACKGROUND: Infections caused by fungi can be important causes of morbidity and mortality in certain patient populations, including those who are highly immunocompromised or critically ill. Invasive mycoses can be caused by well-known species, as well as emerging pathogens, including those that are resistant to clinically available antifungals. CONTENT: This review highlights emerging fungal infections, including newly described species, such as Candida auris, and those that having undergone taxonomic classification and were previously known by other names, including Blastomyces and Emergomyces species, members of the Rasamsonia argillacea species complex, Sporothrix brasiliensis, and Trichophyton indotinae. Antifungal resistance also is highlighted in several of these emerging species, as well as in the well-known opportunistic pathogen Aspergillus fumigatus. Finally, the increased recognition and importance of fungal co-infections with respiratory pathogens, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is discussed. SUMMARY: Both clinicians and clinical microbiology laboratories should remain vigilant regarding emerging fungal infections. These may be difficult both to diagnose and treat due to the lack of experience of clinicians and laboratory personnel with these organisms and the infections they may cause. Many of these fungal infections have been associated with poor clinical outcomes, either due to inappropriate therapy or the development of antifungal resistance. Twit Text FOAVip Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance ????Clin Chem http://www.kidney.de/pget.php?&tw=1&pmid=34969112 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34969112 #FOAvip English Wikipedia <ref>{{Cite pmid|34969112}}</ref> Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance #MMPMID34969112 Wiederhold NP Clin Chem 2021[Dec]; 68 (1): 83-90 PMID34969112show ga BACKGROUND: Infections caused by fungi can be important causes of morbidity and mortality in certain patient populations, including those who are highly immunocompromised or critically ill. Invasive mycoses can be caused by well-known species, as well as emerging pathogens, including those that are resistant to clinically available antifungals. CONTENT: This review highlights emerging fungal infections, including newly described species, such as Candida auris, and those that having undergone taxonomic classification and were previously known by other names, including Blastomyces and Emergomyces species, members of the Rasamsonia argillacea species complex, Sporothrix brasiliensis, and Trichophyton indotinae. Antifungal resistance also is highlighted in several of these emerging species, as well as in the well-known opportunistic pathogen Aspergillus fumigatus. Finally, the increased recognition and importance of fungal co-infections with respiratory pathogens, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is discussed. SUMMARY: Both clinicians and clinical microbiology laboratories should remain vigilant regarding emerging fungal infections. These may be difficult both to diagnose and treat due to the lack of experience of clinicians and laboratory personnel with these organisms and the infections they may cause. Many of these fungal infections have been associated with poor clinical outcomes, either due to inappropriate therapy or the development of antifungal resistance. |*Antifungal Agents/pharmacology[MESH] |*Drug Resistance, Fungal[MESH] |*Mycoses/drug therapy/epidemiology[MESH] |COVID-19[MESH] |Communicable Diseases, Emerging/*epidemiology/microbiology[MESH] |Fungi/drug effects/pathogenicity[MESH]Emerging Fungal Infections: New Species, New Names, and Antifungal Res(epmc).pdf DeepDyve Pubget Overpricing